封面
市场调查报告书
商品编码
1534415

日本健康科技市场:依科技、竞争格局、应用、最终用户、趋势分析、竞争格局、预测,2019-2030

Japan HealthTech Market, By Technology; By Component; By Application; By End User, Trend Analysis, Competitive Landscape & Forecast, 2019-2030

出版日期: | 出版商: Blueweave Consulting | 英文 200 Pages | 商品交期: 2-3个工作天内

价格

日本健康科技市场规模将以6.16%的复合年增长率大幅扩张,2030年将超过6.9512亿美元

由于都市区对医疗和护理的需求不断增加以及医疗保健领域的劳动力短缺,日本的健康科技市场正在蓬勃发展。

领先的策略咨询和市场研究公司 BlueWeave Consulting 在最近的一项研究中估计,2023 年日本健康科技市场规模为 3.4648 亿美元。 BlueWeave 预测,在 2024 年至 2030 年的预测期内,日本健康科技市场规模将以 6.16% 的复合年增长率扩大,到 2030 年将达到 6.9512 亿美元。日本人口老化以及穿戴式装置和行动医疗行动医疗等医疗保健技术的不断涌现是日本医疗保健技术市场的主要驱动因素。在预测期内,日本健康科技市场也预计将受到护理和医疗领域劳动力严重短缺的推动。

机会:糖尿病和其他慢性病的高盛行率

日本健康科技市场按应用细分为循环系统、糖尿病、神经科、睡眠呼吸中止症、肿瘤学等。由于日本慢性病的高盛行率,糖尿病细分市场占了最大的市场。根据美国卫生研究院的数据,目前约有 13.5% 的日本人口患有第 2 型糖尿病(葡萄糖耐受不良)。医疗保健技术透过连续血糖监测 (CGM) 系统、智慧胰岛素笔、即时健康资料、定性低血糖警报等促进更好的糖尿病管理,帮助医疗保健提供者做出明智的决策。

地缘政治紧张局势加剧对日本医疗科技市场的影响

地缘政治紧张局势升级可能会扰乱日本的医疗科技市场。由于以色列提供的技术资产,日本和以色列在健康科技领域有着密切的关係。然而,反以色列分裂运动日益兴起,可能会破坏两国之间的潜在合作。缺乏人力和资金是阻碍以色列科技业营运的另一个因素,这可能对日本医疗科技市场产生直接影响并限制其扩张。

日本健康科技市场

按细分市场分類的覆盖范围

日本健康科技市场:依最终用户分类

按最终用户划分,日本医疗保健市场分为医疗保健提供者、医疗保健付款人、医疗保健消费者、製药公司等。医疗消费领域主导日本健康科技市场。此细分市场的成长主要归因于健康技术设备的不断推出以及患者照护服务的可用性和可及性的提高。医疗保健在获得医疗服务方面为患者提供了许多便利,例如远端监控和获取健康资讯。患者可以远端追踪并与医疗专业人员共用他们的健康状况,这是市场成长的主要推动力。

竞争格局

在日本健康科技市场营运的主要企业包括 Allm Inc.、M3, Inc.、Omron、Whill、FiNC、CureApp、AI Medical Service、Awarefy 和 iCARE。为了进一步增加市场占有率,这些公司正在采取各种策略,例如併购、合作、合资、授权合约和新产品发布。

该报告的详细分析提供了有关日本成长潜力、未来趋势和健康技术市场的资讯。它还涵盖了推动市场总规模预测的因素。该报告致力于提供日本健康科技市场的最新技术趋势和产业见解,并协助决策者做出明智的策略决策。此外,我们也分析了市场的成长动力、挑战和竞争力。

目录

第一章 研究框架

第 2 章执行摘要

第三章 日本健康科技市场洞察

  • 产业价值链分析
  • DROC分析
    • 生长促进因子
      • 日本快速老化
      • 都市区医疗、护理需求不断增加
      • 医疗、护理领域人力资源短缺
      • COVID-19 大流行加速了对数位健康解决方案的需求
    • 抑制因素
      • 数位医疗解决方案报销系统不成熟
      • 老年人收入有限,因此很难将解决方案收益
      • 语言障碍。大多数人不会说英语
    • 机会
      • 远端医疗、电子处方笺和数位健康应用程式报销将改变游戏规则
      • 健康和预防医学领域很有吸引力,因为人们愿意自掏腰包。
      • 日本人人寿保险公司正在投资数位健康解决方案并进行併购
      • 与美国的监管协调将放宽医疗设备的市场准入
    • 任务
      • 平衡技术进步与患者参与并了解当地议题和价值提案
      • 开发适合日本市场的创新且盈利的经营模式
      • 寻找合适的当地合作伙伴进行分销、促销和市场进入
      • 了解监理核准流程和报销制度
  • 科技进步/最新趋势
  • 法律规范
  • 波特五力分析

第四章日本健康科技市场:行销策略

第五章 日本健康科技市场概况

  • 2019-2030年市场规模及预测
    • 按金额
  • 市场占有率及预测
    • 依技术
      • 数位医疗系统
      • 健康分析
      • 医疗资讯技术
      • 行动医疗(行动医疗)
      • 远端医疗
    • 按成分
      • 硬体
      • 软体
      • 服务
    • 按用途
      • 心臟病
      • 糖尿病
      • 神经
      • 睡眠呼吸中止症
      • 其他的
    • 按最终用户
      • 医疗服务提供方
      • 医疗保健付款人
      • 医疗保健消费者
      • 製药公司
      • 其他的

第六章 竞争状况

  • 主要企业名单及其范围
  • 2023年日本健康科技公司市场占有率分析
  • 透过管理参数进行竞争基准化分析
  • 主要策略发展(合併、收购、联盟)

第七章 地缘政治紧张局势加剧对日本医疗科技市场的影响

第八章 公司简介(公司简介、财务矩阵、竞争格局、关键人员、主要竞争对手、联络方式、策略展望、SWOT分析)

  • Allm Inc.
  • M3, Inc.
  • Omron
  • Whill
  • FiNC
  • CureApp
  • AI Medical Service
  • Awarefy
  • iCARE
  • 其他主要企业

第九章 主要战略建议

第10章调查方法

Product Code: BWC24490

Japan HealthTech Market Size Expands at Significant CAGR of 6.16% to Surpass Value of USD 695.12 Million by 2030

Japan HealthTech Market is flourishing because of an increasing demand for medical and nursing care in urban areas and labor shortage in the healthcare care sector.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Japan HealthTech Market size at USD 346.48 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Japan HealthTech Market size to expand at a CAGR of 6.16% reaching a value of USD 695.12 million by 2030. The country's aging population and the increasing introduction of healthcare technology, such as wearables and mHealth applications, are key drivers of the Japan Healthtech Market. Over the forecast period, Japan Healthtech Market is also expected to be driven by a severe labor shortage in the nursing and medical care sectors.

Opportunity: High Prevalence of diabetes and other chronic diseases

Japan HealthTech Market, based on application, is segmented into cardiology, diabetes, neurology, sleep apnea, oncology, and others. The diabetic segment holds the largest share in the market owing to the high prevalence of the chronic disease in Japan. According to the National Institutes of Health, currently, type 2 diabetes, or impaired glucose tolerance, affects around 13.5% of the population in Japan. Healthtech facilitates better management of diabetes through continuous glucose monitoring (CGM) system, smart insulin pens, real-time health data, qualitative hypoglycemia alarms, and others, which allows healthcare providers to make informed decisions.

Impact of Escalating Geopolitical Tensions on Japan HealthTech Market

The escalating geopolitical tensions may disrupt the Japan Healthtech market. Japan and Israel have close ties in the healthtech sector owing to the technological assets offered by the latter. However, divestment campaigns against Israel are being launched, which might impede potential collaboration between the two nations. Lack of manpower and funding is another factor impeding Israel's technology sector operations, which might have a direct impact on Japan Healthtech Market and may restrict its expansion.

Japan HealthTech Market

Segmental Coverage

Japan HealthTech Market - By End User

Based on end user, Japan HealthTech Market is segmented into healthcare providers, healthcare payers, healthcare consumers, pharmaceutical companies, and others. The healthcare consumers segment dominates Japan Healthtech Market. The growth of the segment is mainly attributed to the increasing launches of healthtech devices and the rising availability and accessibility of patient-care services. Healthtech offers many conveniences to patients in terms of healthcare accessibility, such as remote monitoring and access to health information. Patients can track and share their vitality with their healthcare professionals remotely, which acts as a major driving force for market growth.

Competitive Landscape

Major players operating in Japan HealthTech Market include Allm Inc., M3, Inc., Omron, Whill, FiNC, CureApp, AI Medical Service, Awarefy, and iCARE. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and Japan HealthTech Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Japan HealthTech Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Japan HealthTech Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Japan's Rapidly Aging Population
      • 3.2.1.2. Increased Demand for Medical and Nursing Care in Urban Areas
      • 3.2.1.3. Labor Shortage in the Medical and Nursing Care Sectors
      • 3.2.1.4. COVID-19 Pandemic has Accelerated the Need for Digital Health Solutions
    • 3.2.2. Restraints
      • 3.2.2.1. Immature Reimbursement System for Digital Health Solutions
      • 3.2.2.2. Elderly Population has Limited Income, Making it Difficult to Monetize Solutions
      • 3.2.2.3. Language Barrier, as Most People don't Speak English
    • 3.2.3. Opportunities
      • 3.2.3.1. Telemedicine, E-Prescriptions, and Reimbursement for Digital Health Apps will be Game-Changers
      • 3.2.3.2. Wellness and Preventive Medicine Segments are Attractive, as People are Willing to Pay Out-Of-Pocket
      • 3.2.3.3. Japanese Life Insurers are Investing in Digital Health Solutions and Conducting M&A
      • 3.2.3.4. Harmonization of Regulations with the U.S. is Making Market Entry Easier for Medical Devices
    • 3.2.4. Challenges
      • 3.2.4.1. Balancing Tech Push with Patient Pull and Understanding the Local Problem and Value Proposition
      • 3.2.4.2. Developing Innovative, Profitable Business Models suited to the Japanese Market
      • 3.2.4.3. Finding the Right Local Partner for Distribution, Promotion, and Market Access
      • 3.2.4.4. Navigating the Regulatory Approval Process and Reimbursement System
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Japan HealthTech Market: Marketing Strategies

5. Japan HealthTech Market Overview

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology
      • 5.2.1.1. Digital Health Systems
      • 5.2.1.2. Health Analytics
      • 5.2.1.3. Health Information Technology
      • 5.2.1.4. mHealth
      • 5.2.1.5. Telehealthcare
    • 5.2.2. By Component
      • 5.2.2.1. Hardware
      • 5.2.2.2. Software
      • 5.2.2.3. Services
    • 5.2.3. By Application
      • 5.2.3.1. Cardiology
      • 5.2.3.2. Diabetes
      • 5.2.3.3. Neurology
      • 5.2.3.4. Sleep Apnea
      • 5.2.3.5. Oncology
      • 5.2.3.6. Others
    • 5.2.4. By End User
      • 5.2.4.1. Healthcare Providers
      • 5.2.4.2. Healthcare Payers
      • 5.2.4.3. Healthcare Consumers
      • 5.2.4.4. Pharmaceutical Companies
      • 5.2.4.5. Others

6. Competitive Landscape

  • 6.1. List of Key Players and Their Range
  • 6.2. Japan HealthTech Company Market Share Analysis, 2023
  • 6.3. Competitive Benchmarking, By Operating Parameters
  • 6.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

7. Impact of Escalating Geopolitical Tensions on Japan HealthTech Market Industry

8. Company Profiles (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook, and SWOT Analysis)

  • 8.1. Allm Inc.
  • 8.2. M3, Inc.
  • 8.3. Omron
  • 8.4. Whill
  • 8.5. FiNC
  • 8.6. CureApp
  • 8.7. AI Medical Service
  • 8.8. Awarefy
  • 8.9. iCARE
  • 8.10. Other prominent players

9. Key Strategic Recommendations

10. Research Methodology

  • 10.1. Qualitative Research
    • 10.1.1. Primary & Secondary Research
  • 10.2. Quantitative Research
  • 10.3. Market Breakdown & Data Triangulation
    • 10.3.1. Secondary Research
    • 10.3.2. Primary Research
  • 10.4. Breakdown of Primary Research Respondents
  • 10.5. Assumption & Limitation

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

List of Figures

  • Figure 1 Japan HealthTech Market Segmentation
  • Figure 2 Japan HealthTech Market Value Chain Analysis
  • Figure 3 Company Market Share Analysis, 2023
  • Figure 4 Japan HealthTech Market Size, By Value (USD Million), 2019-2030
  • Figure 5 Japan HealthTech Market Share, By Technology, By Value, 2019-2030
  • Figure 6 Japan HealthTech Market Share, By Component, By Value, 2019-2030
  • Figure 7 Japan HealthTech Market Share, By Application, By Value, 2019-2030
  • Figure 8 Japan HealthTech Market Share, By End User, By Value, 2019-2030

List of Tables

  • Table 1 Japan HealthTech Market Share, By Technology, By Value, 2019-2030
  • Table 2 Japan HealthTech Market Share, By Component, By Value, 2019-2030
  • Table 3 Japan HealthTech Market Share, By Application, By Value, 2019-2030
  • Table 4 Japan HealthTech Market Share, By End User, By Value, 2019-2030
  • Table 5 Allm Inc. Company Overview
  • Table 6 Allm Inc. Financial Overview
  • Table 7 M3, Inc. Company Overview
  • Table 8 M3, Inc. Financial Overview
  • Table 9 Omron Company Overview
  • Table 10 Omron Financial Overview
  • Table 11 Whill Company Overview
  • Table 12 Whill Financial Overview
  • Table 13 FiNC Company Overview
  • Table 14 FiNC Financial Overview
  • Table 15 CureApp Company Overview
  • Table 16 CureApp Financial Overview
  • Table 17 AI Medical Service Company Overview
  • Table 18 AI Medical Service Financial Overview
  • Table 19 Awarefy Company Overview
  • Table 20 Awarefy Financial Overview
  • Table 21 iCARE Company Overview
  • Table 22 iCARE Financial Overview